The Medicines Co. Prices $150M Private Notes Offering
By Adam Rhodes · December 14, 2018, 6:36 PM EST
The Medicines Co. said late Thursday that it priced a $150 million private convertible senior notes offering, the proceeds of which the New Jersey-based biopharmaceutical company plans to use to fund...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login